TheraRadar
Clinical-Stage Companies / Jemincare

Jemincare

Pre-Approval PRO BETA
25
Total Trials
2
Phase 3
8
Phase 2
11
Recruiting
186
Score

Pipeline by Phase

Phase 3
2
Phase 2
8
Phase 1
14

Therapeutic Focus

ADPKD (Autosomal Dominant Polycystic Kidney Disease) Healthy Chronic Spontaneous Urticaria Allergic Diseases Perennial Allergic Rhinitis

Clinical Trials (25)

NCT07402213 Phase 3 NOT YET RECRUITING

Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.

Started: 3/31/2026

NCT07242274 Phase 3 NOT YET RECRUITING

Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC

Started: 12/31/2025

NCT06670534 Phase 2 RECRUITING

A Dose-finding Study of JMKX003142 in Treatment of Renal Edema

Started: 1/7/2025

NCT06800651 Phase 2 RECRUITING

Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Started: 3/13/2025

NCT06664125 Phase 2 RECRUITING

Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia

Started: 12/30/2024

NCT06509334 Phase 2 RECRUITING

Trial of JYB1904 in Chronic Spontaneous Urticaria.

Started: 8/4/2024

NCT06221241 Phase 2 RECRUITING

Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain

Started: 3/25/2024

NCT07459452 Phase 2 NOT YET RECRUITING

Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis

Started: 4/1/2026

NCT06438757 Phase 2 ACTIVE NOT RECRUITING

Trial of JYB1904 in Patients With Allergic Asthma

Started: 6/19/2024

NCT06949020 Phase 2 NOT YET RECRUITING

A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema

Started: 6/1/2025

NCT07208136 Phase 1 RECRUITING

A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors

Started: 10/22/2025

NCT06946927 Phase 1 RECRUITING

A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation

Started: 6/6/2025

NCT06740019 Phase 1 RECRUITING

A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

Started: 12/28/2024

NCT06549309 Phase 1 RECRUITING

Trial of JMKX003801 in Healthy Participants

Started: 8/17/2024

NCT06321250 Phase 1 RECRUITING

A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma

Started: 3/14/2024

NCT07513857 Phase 1 NOT YET RECRUITING

Trial of JYB1904 Injection in Adolescent Participants

Started: 5/17/2026

NCT07470177 Phase 1 NOT YET RECRUITING

A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults

Started: 3/27/2026

NCT07463053 Phase 1 NOT YET RECRUITING

Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers

Started: 3/18/2026

NCT07181265 Phase 1 NOT YET RECRUITING

Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects

Started: 10/30/2025

NCT06832657 Phase 1 NOT YET RECRUITING

Study of JMKX003948 Ophthalmic Suspension in Healthy Participants

Started: 2/1/2025

NCT06658964 Phase 1 NOT YET RECRUITING

Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects

Started: 11/5/2024

NCT06473948 Phase 1 NOT YET RECRUITING

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

Started: 7/10/2024

NCT06066060 Phase 1 COMPLETED

A DDI Study of JMKX000623 and Metformin Hydrochloride

Started: 9/17/2023

NCT05449535 Phase 1 COMPLETED

Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects

Started: 5/7/2022

NCT06880848 Phase 4 COMPLETED

Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

Started: 6/21/2023

Drug Candidates

JYB1904 JMKX003142 tablets Placebo [14C]JMKX003142 [14C]JMKX003142 solution for infusion Placebo+JYB1904 JMKX005425 JMKX001899 Docetaxel Sonidegib Phosphate Capsules
Activity Status: Active
Last Trial Started: 5/17/2026
Last Trial Ended: 8/26/2025
Trials (12 months): 10
Completed Trials: 3
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.